Navigation Links
ViewRay Incorporated Closes $15M Tranche of Series B Financing and Announces Partnership with Siemens AG
Date:4/13/2009

OAKWOOD VILLAGE, Ohio, April 14 /PRNewswire/ -- ViewRay Incorporated, a medical device company, announces the close of the second tranche of their $25M Series B financing. Funding was triggered by the company's achievement of a major milestone towards the development of their image guided cancer therapy device, the Renaissance(TM) System. The financing was led by OrbiMed Advisors and Fidelity Biosciences, and was joined by Aisling Capital and Kearny Venture Partners.

"These funds will allow us to continue developing our novel radiation therapy device for the treatment of cancer patients. We believe our system's simultaneous real-time volumetric imaging may provide a tremendous clinical advantage over systems in use today," said Dr. James F. Dempsey, founder and inventor of the technology, and Chief Scientific Officer of the company.

Additionally, the company is announcing that it has entered into an exclusive development and supply agreement with Siemens AG, Healthcare Sector for magnetic resonance imaging (MRI) technology. This collaboration will accelerate the development of ViewRay's Renaissance(TM) System.

"Siemens is a recognized leader in the field of MRI and their expertise in this area will enable us to incorporate state-of-the-art imaging technology into our product," said Dr. John L. Patrick, Senior V.P. of Engineering.

"We are excited to work with ViewRay to explore the capabilities of MR beyond diagnostics and into the field of radiation therapy with a clear goal to improve therapy treatment to the benefit of the patient," said Walter Marzendorfer, head of Magnetic Resonance, Siemens AG, Healthcare Sector.

About ViewRay Incorporated:

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patien
'/>"/>

SOURCE ViewRay Incorporated
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
2. MultiCell Technologies Signs Worldwide Exclusive License Agreement With Corning Incorporated
3. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
4. Genta Incorporated to Present at Lazard Capital Markets 4th Annual Healthcare Conference
5. Genta Incorporated to Present at the BIO CEO & Investor Conference
6. Auditors for Genta Incorporated Express Going Concern Qualification
7. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
8. Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference
9. Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
10. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
11. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Newswire-FirstCall/--Sigma-AldrichCorporation(Nasd...onTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/...tovertheInternetavailableat http://inve s tor.s...t"icontoaccessthisfile. ,, AboutSigma-Aldrich...logycompany.Itschemicalandbiochemicalproductsandki...
(Date:11/24/2009)...Newswire-Asia/--ShanghaiBiolaxyannouncedthe,Chines...the,investigationalnewdrugapplication(IND)foritsor...lationtotreatdiabetes.ThisIND,approvalallowsBiolax...betesisadisordercharacteristicofhighbloodglucosean...sultinseveremicro-and,macro-vasculardiseases,losso...
(Date:11/24/2009)...PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: S...today,announcedthatithassubmittedaMAAtotheEuropean...nzymereplacementtherapyindevelopment,forthetreatme...plicationforvelaglucerasealfathathasbeensubmitted,.... , Basedonaglobalsupplyshortageofthecurrentl...
(Date:11/24/2009)...Chemical Abstracts Service (CAS), the global exper...tent office is now the world,s leading producer of... trailed Japan,s patent office, the World Intellec...States Patent and Trademark Office (USPTO) for mor...O in 2006, and exceeded Japan for the first time o...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 2China Leads All Nations in Publication of Chemical Patents According to CAS, the World's Most Authoritative Publisher of Chemical Information 3
...acksburg, Va. -- The ubiquity of mineral nanoparti...ls and their intriguing properties provide Earth s...stand our planet. , So states a team of scientist...he March 21, 2008, issue of Science, Nanominerals,...e way minerals influence earth is more complex tha...
...ebcast and Conference Call Scheduled for Thursday,... ET, TUCSON, Ariz., March 20 ImaRx Therapeuti...Company will host a live,webcast and conference ca...,discuss corporate updates and fourth quarter 2007...ssed through ImaRx,s corporate website at, http://...
...LIS, Md., March 20 PharmAthene, Inc.,(Amex: PIP ...easures against,biological and chemical threats, t...release for the full year ended December 31, 2007.... today, March 20, 2008. PharmAthene,will schedule ...conference,call at a later time., The conference ...
Other Biology Technology:Nanoscience will change the way we think about the world 2Nanoscience will change the way we think about the world 3Nanoscience will change the way we think about the world 4Nanoscience will change the way we think about the world 5ImaRx to Report Corporate Updates and 4Q07 Financial Results 2
(Date:11/23/2009)...ty-associated strain of the deadly superbug MRSAan...on antibioticsposes a far greater health threat th...pitals, according to a study in the December issue...hreat is easily picked up in fitness centers, scho... overall burden of MRSA within hospitals, the repo...
(Date:11/23/2009)...- The time of day matters to forest trees dealing ... a research team led by Professor Malcolm Campbell...al for research and colleagues in the department o...s. , Capitalizing on their previous work to de...eam examined how poplar trees use their 45,000 gen...
(Date:11/23/2009)...60 participants gathered this week for the seventh... conference. This year,s topic, "Synthetic Biology...ical researchers to explore the engineering, scien...field of synthetic biology. , Bonnie L. Bassler,...rsity and this year,s conference chair, challenged...
Breaking Biology News(10 mins):New study finds MRSA on the rise in hospital outpatients 2Time of day matters to thirsty trees, U of T researcher discovers 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2AHIP Statement on Release of Finance Committee Chairmans Mark 57424 1AHIP Statement on Release of Finance Committee Chairmans Mark 57424 2September 2009 Mayo Clinic Womens HealthSource Highlights Ovarian Cancer Salt and Breaking a Sweat 57422 1September 2009 Mayo Clinic Womens HealthSource Highlights Ovarian Cancer Salt and Breaking a Sweat 57422 2September 2009 Mayo Clinic Womens HealthSource Highlights Ovarian Cancer Salt and Breaking a Sweat 57422 3September 2009 Mayo Clinic Womens HealthSource Highlights Ovarian Cancer Salt and Breaking a Sweat 57422 4September 2009 Mayo Clinic Womens HealthSource Highlights Ovarian Cancer Salt and Breaking a Sweat 57422 5AFSCME President McEntee 3A 22Finance Committee Health Care Bill is Deeply Flawed 22 57421 1
...UC Davis study says that people trying to help nat...ink more naturally. , "Human beings tend to think...nature can be much more irregular," said UC Davis,...,s lead author. "We,found that symmetrical systems...l communities than designs with some randomness or...
...nvironment may play a greater role in the disparit...with hypertension compared to non-Hispanic whites ...hns Hopkins Bloomberg School of Public Health foun...n comparing groups of African Americans and non-Hi...s. The results are published in the November 2008 ...
...LE #1 FOR IMMEDIATE RELEASE , LEDs may help...: American Chemical Society , Researchers in Germ...x and cosmetic surgery for easing facial wrinkles....f ACS, Crystal Growth & Design, a bi-monthly jou...om light emitting diodes (LEDs) applied daily for ...
Other Biology News:Hypertension disparity linked to environment 2American Chemical Society Weekly PressPac Oct. 15, 2008 2American Chemical Society Weekly PressPac Oct. 15, 2008 3American Chemical Society Weekly PressPac Oct. 15, 2008 4American Chemical Society Weekly PressPac Oct. 15, 2008 5American Chemical Society Weekly PressPac Oct. 15, 2008 6American Chemical Society Weekly PressPac Oct. 15, 2008 7American Chemical Society Weekly PressPac Oct. 15, 2008 8
...r 211 ] affinity isolated antibody aqueous solut...aline (without Mg 2+ and Ca 2+ ), pH 7.3, with 1....um azide. a synthetic phosphorylated peptide deriv...sine 207 and serine 209 (corresponding to tyrosine...
Max-Power 2000V Power Supply from Major Science
Chicken Anti-Rab GDP dissociation inhibitor beta Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Microfluidic Power Supply from Major Science
Biology Products: